Surveys

Guidelines for Surveys of Membership

Approval is required to advertise surveys to the ARA Membership. The procedure for Surveys of the Membership can be found here.
Please advise:

  • What are the broad aims of the survey?
  • Why are you doing the survey i.e. is it a trainee research project?
  • The target audience ie rheumatologists, trainees, non-medical members?
  • What are you trying to achieve?
  • Does the study have ethics approval? If so, please supply the HREC committee and the relevant ethics approval.
  • Is it endorsed by a member of the ARA or one of its committees or groups?
  • The time period of the survey ie when does it finish?
  • If you are planning for the responses to be anonymised, then it is best not to include the postcode as one of the questions. Due to the small number of ARA members, inclusion of a postcode will likely allow identification even if names are not included within the survey response.


Please enclose a copy of the survey, the research protocol and ethics approval with your application and send to ara@rheumatology.org.au.

Developing a Core Outcome Set for Sjögren’s Disease

https://redcap.med.upenn.edu/surveys/?s=XDM8WXPLFKC8NWFT

You are invited to take part in the OMERACT Sjögren’s Disease Delphi Study, an international consensus effort to define the Core Domain Set—the essential outcome domains that should be measured in all clinical trials of primary Sjögren’s disease. This work, led by the OMERACT Sjögren’s Working Group, brings together clinicians, researchers, and Patient Research Partners to ensure that both biological and patient-reported aspects of Sjögren’s are represented.

This is a Delphi process with four survey rounds. This project has local Research Ethics approval (Central Adelaide Local Health Network No. 22515).

To participate and to read the consent form, please click here.

For further information, please contact Adrian Lee or Maureen Rischmueller.

Survey Closes: Saturday 16 May 2026

Date Posted: 6 May 2026

Multiple Advanced Therapies in Inflammatory Diseases, the MAT study

Click here to complete the survey.

Do you have patients on or ≥2 advanced immunosuppressive therapies (eg biological agents) concurrently that are not typically used in combination?

Researchers from the University of Sydney are looking to assess the important and emerging area of outcomes of these patients, via an online de-identified registry. All data is stored securely and in the strictest of confidence, and the study has been granted Human Research Ethics Committee approval.

Please follow this link for the database to fill out patient details or receive further details. The survey takes 5-10 minutes (per patient). Any clinician who fills ≥10 patients will be offered co-authorship on the academic output.

Many thanks in advance for your time

Dr John Chetwood (john.chetwood@health.nsw.gov.au)
On behalf of the
The Multiple Advanced Therapies Research Team 

Survey Closes: 29 May 2026

Date Posted: 4 January 2024

Current practice of corticosteroid injection for common foot and ankle conditions in Australia

Click here to complete the survey.

Researchers at La Trobe University are completing a study about the current use of corticosteroid injection for foot and ankle conditions. This research is being done to learn more about the corticosteroid, local anaesthetics, and injection techniques that are being used in Australia for common foot and ankle conditions. This research is being completed as part of an Honours project.

There are a range of corticosteroids, anaesthetics, and injection techniques used to administer corticosteroid injection, with selection of each variable currently based on opinion. Past research has found that selection of corticosteroid and injection techniques varies across disciplines and geographical regions, however there is no research that has evaluated corticosteroid injection use for foot and ankle conditions by Australian health professionals. Understanding how Australian health professionals use corticosteroid injection to manage common foot and ankle conditions can inform future randomised trials comparing the effectiveness of corticosteroids and injection techniques.

We hope to learn about the corticosteroid, local anaesthetics, and injection techniques that are being used in Australia for common foot and ankle conditions. Understanding this can inform future randomised trials comparing the effectiveness of corticosteroids and injection techniques.

Recruitment of Participants and Selection Criteria
Participants will be health professionals who currently practice in Australia and administer corticosteroid injection to manage foot and ankle conditions. The health professionals that will be targeted for this study include orthopaedic surgeons, radiologists, rheumatologists, podiatrists, and podiatric surgeons.

Inclusion/Exclusion Criteria

  • A health professional registered with AHPRA
  • Reside in Australia 
  • Use a primary language that is the same as the researchers
  • Have administered at least 1 corticosteroid injection for a foot or ankle condition in the past 6 months

Survey Closes: 31 May 2026

Date Posted: 25 February 2025